Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2007 1
2008 2
2010 1
2011 1
2013 1
2014 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S; SAPPHIRE Investigators. Borghaei H, et al. Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20. Ann Oncol. 2024. PMID: 37866811 Clinical Trial.
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
Abdel-Karim I, Plunkett WK Jr, O'Brien S, Giles F, Thomas D, Faderl S, Ravandi F, Rios MB, Du M, Schneck KB, Chen VJ, Lin BK, Nicol SJ, Kantarjian HM. Abdel-Karim I, et al. Invest New Drugs. 2011 Apr;29(2):323-31. doi: 10.1007/s10637-009-9369-7. Epub 2010 Jan 21. Invest New Drugs. 2011. PMID: 20091088 Free PMC article. Clinical Trial.
Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris.
Sharifi M, Fares W, Abdel-Karim I, Koch JM, Sopko J, Adler D; Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions Investigators. Sharifi M, et al. Among authors: abdel karim i. Am J Cardiol. 2004 Jun 15;93(12):1533-5. doi: 10.1016/j.amjcard.2004.03.009. Am J Cardiol. 2004. PMID: 15194029 Clinical Trial.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA; START trial team. Butts C, et al. Lancet Oncol. 2014 Jan;15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9. Lancet Oncol. 2014. PMID: 24331154 Free article. Clinical Trial.
Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality.
Sharifi M, Fares W, Abdel-Karim I, Petrea D, Koch JM, Adler D, Sopko J; Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions (HOT-PI) Investigators. Sharifi M, et al. Among authors: abdel karim i. Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):124-6. doi: 10.1016/s1522-1865(03)00104-5. Cardiovasc Radiat Med. 2002. PMID: 12974361 Clinical Trial. No abstract available.